Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Obama Budget Seeks Prior-Authorization Ability For All Medicare Fee-For-Service Items

This article was originally published in The Gray Sheet

Executive Summary

The administration’s March 4 budget request, repeats past attempts to expand prior-authorization requirements for power wheelchairs and advanced imaging, while also giving CMS the authority to institute prior-authorization for all Medicare fee-for-service items.

You may also be interested in...

Expanded Prior-Authorization Requirements Proposed By CMS

The agency is proposing to pre-authorization rules for certain durable medical equipment and an expansion of the power mobility equipment prior-authorization pilot program, and the creation of new pilot prior-authorization programs for hyperbaric oxygen therapy and repetitive scheduled non-emergent ambulance transport.

Draft SGR Repeal Bill Reworks Doc Incentives, Includes Imaging/ECG Appropriateness Criteria

The Senate Finance Committee and House Ways & Means Committee circulated a discussion draft to replace the maligned Medicare sustainable growth rate formula for physician pay with a system that freezes base payments but offers value-based incentives. The bill also calls for mandatory use of appropriateness criteria for advanced imaging and electrocardiogram, and prior authorization in some cases.

IPAB’s Tough Road: Republicans Opt Not To Help Find Members

House Speaker Boehner and Senate Majority Leader McConnell “respectfully decline” the president’s request to submit names of individuals to serve on the Medicare Independent Payment Advisory Board.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts